PERSISTENCE WITH BISPHOSPHONATE THERAPY AND RISK OF HIP FRACTURE

被引：0
|
作者：
Chodick, G. [1 ]
Shalev, V [1 ]
Sharon, Y. [2 ]
Goldstein, I [1 ]
机构：
[1] Maccabi Healthcare Serv, Tel Aviv, Israel
[2] Tel Aviv Univ, IL-69978 Tel Aviv, Israel
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 03期
关键词：
D O I：
10.1016/j.jval.2011.02.691
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A124 / A124
页数：1
相关论文
共 50 条
  • [21] MONITORING COMPLIANCE AND PERSISTENCE WITH ALENDRONATE THERAPY STARTED AFTER HIP FRACTURE
    Turk, A.
    Fripp, A.
    Ahmed, S.
    Beck, S.
    Johansen, A.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 : S293 - S294
  • [22] RISK AND PROGNOSIS OF ACUTE KIDNEY INJURY IN BISPHOSPHONATE USERS UNDERGOING HIP FRACTURE SURGERY
    Christiansen, Christian
    Shetty, Nisha
    Heide-Jorgensen, Uffe
    Sorensen, Henrik Toft
    Ehrenstein, Vera
    Pedersen, Alma
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [23] Risk and prognosis of acute kidney injury in bisphosphonate users undergoing hip fracture surgery
    Christiansen, Christian Fynbo
    Shetty, Nisha
    Heide-Jorgensen, Uffe
    Sorensen, Henrik Toft
    Ehrenstein, Vera
    Pedersen, Alma Becic
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 348 - 348
  • [24] Better adherence to bisphosphonate therapy is associated with reduced nonvertebral fracture risk
    Sunyecz, John A.
    Bachmann, Gloria
    Barr, Charles E.
    Silverman, Stuart
    OBSTETRICS AND GYNECOLOGY, 2006, 107 (04): : 25S - 25S
  • [25] Bone: Bisphosphonate therapy after cardiac transplant reduces fracture risk
    Wilson C.
    Nature Reviews Endocrinology, 2009, 5 (7) : 356 - 356
  • [26] Persistence of weekly oral bisphosphonate therapy: Wasted drug and fracture costs due to early discontinuation
    Sheehy, Odile
    Kindundu, Christian
    Barbeau, Martin
    LeLorier, Jacques
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 : S78 - S79
  • [27] Improving compliance and persistence with bisphosphonate therapy for osteoporosis
    Emkey, RD
    Ettinger, M
    AMERICAN JOURNAL OF MEDICINE, 2006, 119 (04): : 18S - 24S
  • [28] Incidence of second hip fracture and compliant use of bisphosphonate
    Lee, Y. -K.
    Ha, Y. -C.
    Yoon, B. -H.
    Koo, K. -H.
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 (07) : 2099 - 2104
  • [29] Incidence of second hip fracture and compliant use of bisphosphonate
    Y.-K. Lee
    Y.-C. Ha
    B.-H. Yoon
    K.-H. Koo
    Osteoporosis International, 2013, 24 : 2099 - 2104
  • [30] Bisphosphonate use and subsequent hip fracture in South Korea
    Lee, Y. -K.
    Ha, Y. -C.
    Choi, H. J.
    Jang, S.
    Park, C.
    Lim, Y. -T.
    Shin, C. S.
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 (11) : 2887 - 2892
12345